Back to Virginia

HB998 • 2026

Menstrual products ingredient labeling; restriction of substances, delayed effective date.

An Act to amend the Code of Virginia by adding in Article 23 of Chapter 2 of Title 32.1 a section numbered 32.1-73.28:1, relating to menstrual products ingredient labeling; civil penalty.

Enacted

This bill passed the Legislature and reached final enactment based on the latest official action.

Sponsor
Seibold
Last action
2026-04-06
Official status
Acts of Assembly Chapter
Effective date
Not listed

Plain English Breakdown

The bill text does not specify a timeframe for posting changes online, only that it must be done after six months of any change.

Menstrual Products Ingredient Labeling Law

This law requires menstrual product manufacturers to clearly label all ingredients in their products sold in Virginia and post the information online starting from January 1, 2027.

What This Bill Does

  • Requires menstrual product packages or boxes to have a clear ingredient list visible to consumers.
  • Manufacturers must update labels within 18 months if they change, add, or remove an ingredient.
  • Manufacturers need to put the same ingredient information on their websites.

Who It Names or Affects

  • Menstrual product manufacturers
  • Consumers buying menstrual products in Virginia

Terms To Know

Confidential substance
A secret ingredient that serves a technical or functional purpose and is protected by law.
Ingredient
Any added substance in menstrual products that has a specific job, unless it's a confidential substance.

Limits and Unknowns

  • The law does not apply to products made before January 1, 2027.
  • Some ingredients can be kept secret if they meet certain legal criteria.

Amendments

These notes stay tied to the official amendment files and metadata from the legislature.

HB998ASC1

2026-02-24 • Committee

Education and Health Amendment

Plain English: The amendment changes how violations of menstrual product ingredient labeling rules are handled, making them a prohibited practice under consumer protection laws.

  • Violations of the menstrual products ingredient labeling requirements will now be treated as prohibited practices under Virginia's Consumer Protection Act.
  • The amendment does not specify what specific substances or ingredients are restricted in menstrual products, only how violations of the labeling rules will be enforced.
HB998AS1

2026-02-27 • Committee

Education and Health Amendment

Plain English: The amendment changes how violations of menstrual product ingredient labeling laws are handled, making them a prohibited practice under the Virginia Consumer Protection Act.

  • Violations of menstrual product ingredient labeling rules will now be considered a prohibited practice under the Virginia Consumer Protection Act.
  • The amendment does not provide details on how enforcement provisions will specifically apply to menstrual product labeling violations.
HB998EDOC

2026-03-02 • Senate

Senate Amendment

Plain English: The amendment changes how violations of menstrual product ingredient labeling laws are handled, making them a prohibited practice under the Virginia Consumer Protection Act.

  • Violations of menstrual product ingredient labeling requirements will now be considered a prohibited practice under the Virginia Consumer Protection Act.
  • The amendment does not specify what specific substances or ingredients are restricted in menstrual products, only how violations of the labeling laws will be enforced.
  • It is unclear from this text alone what the current enforcement provisions for these labeling requirements are before this amendment.

Bill History

  1. 2026-04-06 Governor

    Approved by Governor-Chapter 249 (effective 7/1/2026)

  2. 2026-04-06 Governor

    Approved by Governor-Chapter 249 (effective 7/1/2026)

  3. 2026-04-06 Governor

    Acts of Assembly Chapter text (CHAP0249)

  4. 2026-03-14 House

    Enrolled Bill communicated to Governor on March 14, 2026

  5. 2026-03-14 Governor

    Governor's Action Deadline 11:59 p.m., April 13, 2026

  6. 2026-03-12 House

    Signed by Speaker

  7. 2026-03-11 Senate

    Signed by President

  8. 2026-03-11 House

    Enrolled

  9. 2026-03-11 House

    Bill text as passed House and Senate (HB998ER)

  10. 2026-03-11 House

    Fiscal Impact Statement from Department of Planning and Budget (HB998)

  11. 2026-03-04 House

    Senate amendment agreed to by House (69-Y 25-N 0-A)

  12. 2026-03-02 Senate

    Read third time

  13. 2026-03-02 Senate

    Read third time

  14. 2026-03-02 Senate

    Engrossed by Senate as amended

  15. 2026-03-02 Education and Health

    Education and Health Amendment agreed to

  16. 2026-03-02 Senate

    Passed Senate with amendment (24-Y 16-N 0-A)

  17. 2026-02-27 Senate

    Rules suspended

  18. 2026-02-27 Senate

    Passed by for the day

  19. 2026-02-27 Senate

    Constitutional reading dispensed Block Vote (on 2nd reading) (37-Y 0-N 0-A)

  20. 2026-02-27 Senate

    Passed by for the day Block Vote (Voice Vote)

  21. 2026-02-26 Education and Health

    Reported from Education and Health with amendment (9-Y 3-N)

  22. 2026-02-24 Senate

    Senate committee offered

  23. 2026-02-23 Health and Human Services

    Fiscal Impact Statement from Department of Planning and Budget (HB998)

  24. 2026-02-18 Senate

    Constitutional reading dispensed (on 1st reading)

  25. 2026-02-18 Education and Health

    Referred to Committee on Education and Health

  26. 2026-02-17 House

    Read third time and passed House (69-Y 28-N 0-A)

  27. 2026-02-16 House

    Read second time

  28. 2026-02-16 House

    committee substitute agreed to

  29. 2026-02-16 House

    Engrossed by House - committee substitute

  30. 2026-02-15 House

    Read first time

  31. 2026-02-12 Health and Human Services

    Reported from Health and Human Services with substitute (16-Y 5-N)

  32. 2026-02-12 House

    House committee offered

  33. 2026-02-12 Health and Human Services

    Committee substitute printed 26107800D-H1

  34. 2026-02-10 Health

    Subcommittee recommends reporting with substitute (6-Y 3-N)

  35. 2026-02-10 Health

    House subcommittee offered

  36. 2026-02-06 House

    Fiscal Impact Statement from Department of Planning and Budget (HB998)

  37. 2026-01-23 Health

    Assigned sub: Health

  38. 2026-01-14 House

    Prefiled and ordered printed; Offered 01-14-2026 26104843D

  39. 2026-01-14 Health and Human Services

    Referred to Committee on Health and Human Services

Official Summary Text

Menstrual supplies ingredient labeling; restriction of substances; civil penalty.
Requires that each package or box containing menstrual supplies, as defined in the bill, contain a label of all ingredients that are included within such products when sold within the Commonwealth. Such label shall be displayed by the manufacturer in a manner that is visible and easy to understand for the consumer. The bill requires any manufacturer to make changes to the label reflecting any changes of ingredients within 18 months of any such changes. The bill also requires the manufacturer to post the required label information on its website. The bill has a delayed effective date of January 1, 2027.

Current Bill Text

Read the full stored bill text
An Act to amend the Code of Virginia by adding in Article 23 of Chapter 2 of Title 32.1 a section numbered
32.1-73.28:1
, relating to menstrual products ingredient labeling; civil penalty.
Be it enacted by the General Assembly of Virginia:
1. That the Code of Virginia is amended by adding in Article 23 of Chapter 2 of Title 32.1 a section numbered
32.1-73.28:1
as follows:
§
32.1-73.28:1
. Menstrual products ingredient labeling; civil penalty.
A. As used in this section:
"Confidential substance" means any element or substance that a manufacturer has added to a menstrual product that serves a technical or functional purpose in the finished menstrual product and:
1. For which a claim has been approved by the U.S. Environmental Protection Agency for inclusion on the confidential portion of the Toxic Substances Control Act Chemical Substance Inventory, established pursuant to 15 U.S.C. § 2607(b) and 40 C.F.R. Part 710;
2. For which the manufacturer of the menstrual products or the supplier of the substance claims protection under the federal Defend Trade Secrets Act of 2016 (18 U.S.C. § 1836 et seq.); or
3. That is generally recognized as safe by the U.S. Food and Drug Administration pursuant to 21 C.F.R. § 170.30.
"Ingredient" means any intentionally added substance present in a menstrual product that serves a technical or functional purpose in the finished product, provided that the substance or the combination of substances is not considered a confidential substance.
"Label" means a display of written, printed, or graphic material on or affixed to a container in which the menstrual products are distributed.
"Menstrual product" means a disposable or reusable product manufactured for the purpose of catching menstruation and vaginal discharge, including a tampon, sanitary pad, disc, menstrual cup, and menstrual underwear.
"Package or box containing menstrual products" does not include packaging used exclusively for shipping purposes.
B. Each package or box containing menstrual products manufactured for sale or distribution within the Commonwealth shall contain a label of all ingredients that are included within such menstrual products, with such ingredients listed in descending order of predominance. The label shall be displayed by the manufacturer in a manner that is visible and easy for the consumer to understand. A manufacturer that changes, adds, or removes an ingredient of a menstrual product shall make changes to the label required pursuant to this subsection reflecting such change, addition, or removal within 18 months of such change, addition, or removal. The provisions of this subsection shall not restrict the continued sale of menstrual products manufactured before January 1, 2027.
C. A manufacturer of menstrual products shall post on its website (i) the label information required to be disclosed on each package or box containing menstrual products pursuant to subsection B and (ii) information regarding any change to the label on a menstrual product required pursuant to subsection B after changing, adding, or removing an ingredient within six months of such change, addition, or removal. The manufacturer may use technologies, including a digital link, to communicate information pursuant to this section.
D. No manufacturer of menstrual products sold within the Commonwealth shall be required under this section to disclose a confidential substance on a package or box or on its website. If a manufacturer declines to disclose a confidential substance on a package or box containing menstrual products or on its website in order to protect the identity of such confidential substance, such manufacturer shall include such confidential substance by its common name with the label information required to be disclosed on each package or box containing menstrual products pursuant to subsection B.
E.
Any violation of this section shall constitute a prohibited practice under §
59.1-200
and shall be subject to the enforcement provisions of the Virginia Consumer Protection Act (§
59.1-196
et seq.).
2. That the provisions of this act shall become effective on January 1, 2027.